According to FutureWise analysis the market for Angiotensin Converting Enzyme (ACE) Inhibitors in 2023 is US$ 3.63 billion, and is expected to reach US$ 5.42 billion by 2031 at a CAGR of 5.10%.
Angiotensin Converting Enzyme (ACE) inhibitors are the medication that helps relax the veins and arteries to lower blood pressure. Angiotensin-converting enzyme inhibitors act by inhibiting an enzyme in the body responsible for the production of angiotensin II, a substance that causes the narrowing of blood vessels. This narrowing can lead to elevated blood pressure, placing additional strain on the heart. Angiotensin II is a hormone circulating in the bloodstream, exerting various effects on the cardiovascular system, primarily causing the constriction of blood vessels. Such contraction can result in high blood pressure and increased workload for the heart, especially if it has been weakened due to a heart attack or heart failure. ACE inhibitors exhibit the production of angiotensin II, effectively preventing the constriction of blood vessels. This action leads to a reduction in blood pressure and decreases the amount of energy the heart needs to exert with each heartbeat.
Initially, ACE inhibitors were primarily utilized to reduce high blood pressure (hypertension) by relaxing constricted blood vessels. However, with numerous other effective agents to lower blood pressure, new opportunities emerged for therapy with ACE inhibitors. Specifically, individuals with weakened heart muscles, leading to heart failure, exhibited elevated levels of angiotensin II in their blood. Recognizing this, using ACE inhibitors in such patients proved highly beneficial. It was established that administering ACE inhibitors to individuals with heart failure delayed the onset of symptoms, prevented heart failure-related deaths, and reduced the frequency of hospitalizations. ACE inhibitors were also studied in individuals who had experienced heart attacks but were not yet showing symptoms of heart failure.
FutureWise Market Research has published a report that provides an insightful analysis angiotensin converting enzyme (ACE) inhibitors market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, angiotensin converting enzyme (ACE) inhibitors market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.